US Broker Ratings

BrightSpring Health Services, I (BTSG): Investor Outlook on a 7.64% Upside Potential

BrightSpring Health Services, Inc. (NASDAQ: BTSG), a major player in the healthcare sector, presents an intriguing opportunity for investors seeking exposure to the dynamic field of health information services. With..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Exploring the 16.75% Upside Potential

Madrigal Pharmaceuticals, Inc. (MDGL), a promising player in the biotechnology sector, has captured the attention of investors with its compelling narrative centered on innovative treatments for metabolic dysfunction-associated steatohepatitis (MASH)...

Avidity Biosciences, Inc. (RNA) Investor Outlook: Strong Buy Ratings Signal 42% Upside Potential

Avidity Biosciences, Inc. (RNA), a promising player in the biotechnology sector, is making waves among investors with its innovative approach to tackling diseases through RNA therapeutics. Headquartered in San Diego,..

Telix Pharmaceuticals Limited (TLX): Investor Outlook with 93% Potential Upside

Telix Pharmaceuticals Limited (TLX), an emerging player in the biotechnology sector, has captured the attention of investors with its robust growth potential and a promising pipeline of radiopharmaceuticals. Headquartered in..

Sarepta Therapeutics (SRPT) Stock Analysis: Biotechnology Innovator with a 3.92% Potential Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leading player in the biopharmaceutical space, continues to capture investor attention with its pioneering work in RNA-targeted therapeutics and gene therapies. Headquartered in Cambridge,..

Option Care Health, Inc. (OPCH) Investor Outlook: Unlocking a 38% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH), a leading provider of home and alternate site infusion services in the United States, is capturing the attention of investors with its robust potential..

Guardant Health, Inc. (GH) Stock Analysis: Navigating Growth in Precision Oncology with 6% Upside Potential

Guardant Health, Inc. (NASDAQ: GH) is a key player in the healthcare sector, specifically within the diagnostics and research industry. This precision oncology company, headquartered in Palo Alto, California, is..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Look at Its 11.71% Potential Upside and Strong Buy Consensus

Krystal Biotech, Inc. (NASDAQ: KRYS) is capturing the attention of investors with its innovative approach to genetic medicine and a promising growth trajectory in the biotechnology sector. The company, headquartered..

ADMA Biologics Inc (ADMA) Stock Analysis: Eyeing Nearly 94% Potential Upside with Strong Analyst Confidence

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is drawing attention from investors with its compelling growth metrics and robust market presence in the healthcare industry...

Alkermes plc (ALKS) Stock Analysis: A Promising 38% Upside in the Healthcare Sector

Alkermes plc (NASDAQ: ALKS), a leading biopharmaceutical company headquartered in Dublin, Ireland, is capturing investor interest with a potential 38.02% upside, as suggested by current analyst ratings. Specializing in the..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Stable Path in the Healthcare Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a notable player in the healthcare sector, is making waves with its robust offerings in the medical devices industry. With a market capitalization of $8.26..

RadNet, Inc. (RDNT) Stock Analysis: A Promising Healthcare Bet with 4.73% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the Healthcare sector, particularly in the Diagnostics & Research industry, is catching the eyes of investors with its innovative approach to outpatient..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Biotech with 81.76% Potential Upside and Strong Buy Ratings

Investors seeking opportunities in the dynamic world of biotechnology should take a closer look at Soleno Therapeutics, Inc. (NASDAQ: SLNO). This clinical-stage biopharmaceutical company is attracting significant attention due to..

West Pharmaceutical Services (WST) Stock Analysis: Exploring the 17.98% Potential Upside for Investors

West Pharmaceutical Services, Inc. (NYSE: WST) stands out in the healthcare sector as a key player in the medical instruments and supplies industry. With a substantial market capitalization of $19.46..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Impressive Revenue Growth and Analyst Confidence Highlight Investment Potential

BridgeBio Pharma, Inc. (BBIO), a pioneering entity in the biotechnology industry, has been making waves with its innovative approach to treating genetic diseases and cancers. Based in Palo Alto, California,..

Ascendis Pharma A/S (ASND) Stock Analysis: A 19% Potential Upside Amidst Robust Revenue Growth

For investors seeking compelling opportunities in the biotechnology sector, Ascendis Pharma A/S (NASDAQ: ASND) presents an intriguing case with its notable revenue growth and promising analyst ratings. Operating out of..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Unpacking a 26.1% Revenue Growth Story

For investors eyeing the healthcare sector, iRhythm Technologies, Inc. (NASDAQ: IRTC) offers a compelling opportunity with a market capitalization of $5.84 billion. Specializing in medical devices, specifically ambulatory cardiac monitoring..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: Navigating High Dividend Yields Amidst Negative Earnings

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is a well-known name in the healthcare sector, operating as a pharmaceutical retailer with a presence in the United States and internationally. The company..

Charles River Laboratories (CRL): Investor Outlook with a 4.12% Upside Amidst Healthcare Innovation

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a noteworthy player in the healthcare sector, particularly within the diagnostics and research industry. The company, headquartered in Wilmington, Massachusetts, has..

Teva Pharmaceutical Industries (TEVA): Investor Outlook and Potential 26.59% Upside

Teva Pharmaceutical Industries (NYSE: TEVA) stands as a formidable player in the global healthcare sector, particularly in the specialty and generic drug manufacturing industry. With a market capitalization of $22.93..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds